ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

New CCSP And CCRU Awards Applications Under Review

January 17, 1986

Peter Boyle Elected IARC Director

May 23, 2003

Study: Routine CT Not Needed In Detecting DLBCL Remissions

May 31, 2013

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

June 24, 2011

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012

Funding Opportunities: NCI Request for Applications

April 28, 2000